Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Perrigo Co (PRGO)  
$25.63 0.08 (0.31%) as of 4:30 Thu 9/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 136,480,000
Market Cap: 3.50(B)
Last Volume: 503,160 Avg Vol: 498,450
52 Week Range: $25.43 - $34.14
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Related Products

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P 400 MIDCAP
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Perrigo is a provider of over-the-counter health and wellness solutions that can be self-managed. Co.'s segments are as follows: Consumer Self-Care Americas, which is focused primarily on the sale of self-care products in categories including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements; Consumer Self-Care International, which develops, manufactures, markets, and distributes European consumer self-care brands in the upper respiratory, pain and sleep-aids, digestive health, vitamins, minerals and supplements; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-06-27 2024-03-26 2023-09-26 2022-09-26

   
Records found: 1400
  Page 32 of 56  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Arkin Moshe Director   –       •      –    2009-09-30 4 AS $34.00 $280,228 I/I (8,242) 6,985,230     -
   Arkin Moshe Director   –       •      –    2009-09-29 4 AS $34.04 $969,853 I/I (28,494) 6,993,472     -
   Kingma Todd W Executive VP, General Counsel   •       –      –    2009-09-04 4 GD $0.00 $0 D/D 725 27,679     -
   Kingma Todd W Executive VP, General Counsel   •       –      –    2009-09-04 4 S $29.30 $116,053 D/D (3,960) 28,404     -
   Kingma Todd W Executive VP, General Counsel   •       –      –    2009-09-04 4 OE $13.90 $55,044 D/D 3,960 32,364     -
   Jandernoa Michael J Director   –       •      –    2009-09-03 4 GD $0.00 $0 I/I 3,342 2,511,286     -
   Jandernoa Michael J Director   –       •      –    2009-09-02 4 GD $0.00 $0 I/I 1,528 2,514,628     -
   Jandernoa Michael J Director   –       •      –    2009-09-01 4 GD $0.00 $0 I/I 3,084 2,516,156     -
   Jandernoa Michael J Director   –       •      –    2009-08-28 4 GD $0.00 $0 I/I 760 2,519,240     -
   Jandernoa Michael J Director   –       •      –    2009-08-27 4 GD $0.00 $0 I/I 8,970 2,520,000     -
   Stewart Michael Robert Sr. VP Global Human Resources   •       –      –    2009-08-14 4 D $26.50 $16,324 D/D (616) 5,943     -
   Needham Jeffrey Sr. VP Commercial Business Dev   •       –      –    2009-08-14 4 D $26.50 $34,026 D/D (1,284) 3,746     -
   Hendrickson John T EVP Global Operations & Supply   •       –      –    2009-08-14 4 D $26.50 $38,505 D/D (1,453) 3,988     -
   Shah Jatin Sr VP & Chief Scientific Offic   •       –      –    2009-08-14 4 D $26.50 $25,864 D/D (976) 9,404     -
   Brown Judy L Executive VP & CFO   •       –      –    2009-08-14 4 D $26.50 $36,279 D/D (1,369) 9,085     -
   Kingma Todd W Executive VP, General Counsel   •       –      –    2009-08-14 4 D $26.50 $31,588 D/D (1,192) 24,870     -
   Tomshack James Senior VP of CHC Sales   •       –      –    2009-08-14 4 D $26.50 $36,756 D/D (1,387) 3,113     -
   Kochan Sharon Executive VP U.S. Generics   •       –      –    2009-05-20 4 D $27.11 $79,703 D/D (2,940) 12,754     -
   Jandernoa Michael J Director   –       •      –    2009-05-18 4 D $26.71 $8,466,446 I/I (317,036) 2,528,970     -
   Shah Jatin Sr VP & Chief Scientific Offic   •       –      –    2009-05-14 4 D $26.70 $5,901 D/D (221) 10,380     -
   Kingma Todd W Executive VP, General Counsel   •       –      –    2009-04-03 4 D $23.77 $48,824 D/D (2,054) 26,062     -
   Shah Jatin Sr VP & Chief Scientific Offic   •       –      –    2009-02-04 4 D $23.34 $13,094 D/D (561) 10,601     -
   Jandernoa Michael J Director   –       •      –    2008-12-19 4 GD $0.00 $0 I/I 6,897 2,846,006     -
   Jandernoa Michael J Director   –       •      –    2008-12-18 4 GD $0.00 $0 I/I 6,468 2,852,903     -
   Jandernoa Michael J Director   –       •      –    2008-12-15 4 GD $0.00 $0 I/I 1,225 2,859,371     -
  1400 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 32 of 56
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us